Inventage Lab will participate in BIO-Europe 2026, taking place November 9–11, 2026 at Koelnmesse in Cologne, Germany.
Hosted by Informa Connect (EBD Group), BIO-Europe is Europe's largest biopharma partnering event, bringing together thousands of life science leaders from more than 3,200 companies across over 60 countries. Through the partneringONE platform, the event facilitates a high volume of one-to-one meetings and serves as a central stage for European and global dealmaking.
Inventage Lab is a clinical-stage biotech developing next-generation drug delivery platforms based on its proprietary microfluidic technology. Its platforms include DrugFluidic® for long-acting injectables (LAI) of small molecules and peptides, BioFluidic™ for subcutaneous (SC) formulation optimization of antibody and protein therapeutics, and GeneFluidic®, an LNP platform for nucleic acid-based therapeutics. Each platform is designed to overcome the limitations of conventional formulations and enhance the value of global partners' pipelines.
At BIO-Europe 2026, Inventage Lab will focus on one-to-one partnering meetings, actively exploring co-development, licensing, and CDMO partnership opportunities across indications including obesity and metabolic disease, CNS, and oncology.
Meetings can be requested through the partneringONE platform. We welcome meeting requests from pharmaceutical and biotech companies interested in global partnering.
